Analyses of clinical prostate cancer samples have also suggested that elevated NPY promotes prostate cancer development and is associated with poor prognosis and therapy resistance (Rasiah et al., 2006; Ding et al., 2021). Here, NPY is linked to Familial prostate cancer.